Transplantation outcomes in primary hyperoxaluria

E. J. Bergstralh, C. G. Monico, John C Lieske, R. M. Herges, C. B. Langman, B. Hoppe, D. S. Milliner

Research output: Contribution to journalArticle

91 Citations (Scopus)

Abstract

Optimal transplantation strategies are uncertain in primary hyperoxaluria (PH) due to potential for recurrent oxalosis. Outcomes of different transplantation approaches were compared using life-table methods to determine kidney graft survival among 203 patients in the International Primary Hyperoxaluria Registry. From 1976-2009, 84 kidney alone (K) and combined kidney and liver (K + L) transplants were performed in 58 patients. Among 58 first kidney transplants (32 K, 26 K + L), 1-, 3-and 5-year kidney graft survival was 82%, 68% and 49%. Renal graft loss occurred in 26 first transplants due to oxalosis in ten, chronic allograft nephropathy in six, rejection in five and other causes in five. Delay in PH diagnosis until after transplant favored early graft loss (p = 0.07). K + L had better kidney graft outcomes than K with death-censored graft survival 95% versus 56% at 3 years (p = 0.011). Among 29 year 2000-09 first transplants (24 K + L), 84% were functioning at 3 years compared to 55% of earlier transplants (p = 0.05). At 6.8 years after transplantation, 46 of 58 patients are living (43 with functioning grafts). Outcomes of transplantation in PH have improved over time, with recent K + L transplantation highly successful. Recurrent oxalosis accounted for a minority of kidney graft losses.

Original languageEnglish (US)
Pages (from-to)2493-2501
Number of pages9
JournalAmerican Journal of Transplantation
Volume10
Issue number11
DOIs
StatePublished - Nov 2010

Fingerprint

Primary Hyperoxaluria
Transplantation
Transplants
Kidney
Hyperoxaluria
Graft Survival
Life Tables
Allografts
Registries

Keywords

  • Kidney transplantation
  • liver transplantation
  • oxalosis
  • primary hyperoxaluria

ASJC Scopus subject areas

  • Transplantation
  • Immunology and Allergy
  • Pharmacology (medical)

Cite this

Bergstralh, E. J., Monico, C. G., Lieske, J. C., Herges, R. M., Langman, C. B., Hoppe, B., & Milliner, D. S. (2010). Transplantation outcomes in primary hyperoxaluria. American Journal of Transplantation, 10(11), 2493-2501. https://doi.org/10.1111/j.1600-6143.2010.03271.x

Transplantation outcomes in primary hyperoxaluria. / Bergstralh, E. J.; Monico, C. G.; Lieske, John C; Herges, R. M.; Langman, C. B.; Hoppe, B.; Milliner, D. S.

In: American Journal of Transplantation, Vol. 10, No. 11, 11.2010, p. 2493-2501.

Research output: Contribution to journalArticle

Bergstralh, EJ, Monico, CG, Lieske, JC, Herges, RM, Langman, CB, Hoppe, B & Milliner, DS 2010, 'Transplantation outcomes in primary hyperoxaluria', American Journal of Transplantation, vol. 10, no. 11, pp. 2493-2501. https://doi.org/10.1111/j.1600-6143.2010.03271.x
Bergstralh, E. J. ; Monico, C. G. ; Lieske, John C ; Herges, R. M. ; Langman, C. B. ; Hoppe, B. ; Milliner, D. S. / Transplantation outcomes in primary hyperoxaluria. In: American Journal of Transplantation. 2010 ; Vol. 10, No. 11. pp. 2493-2501.
@article{b657772016cf41e7b98053aaba334b0f,
title = "Transplantation outcomes in primary hyperoxaluria",
abstract = "Optimal transplantation strategies are uncertain in primary hyperoxaluria (PH) due to potential for recurrent oxalosis. Outcomes of different transplantation approaches were compared using life-table methods to determine kidney graft survival among 203 patients in the International Primary Hyperoxaluria Registry. From 1976-2009, 84 kidney alone (K) and combined kidney and liver (K + L) transplants were performed in 58 patients. Among 58 first kidney transplants (32 K, 26 K + L), 1-, 3-and 5-year kidney graft survival was 82{\%}, 68{\%} and 49{\%}. Renal graft loss occurred in 26 first transplants due to oxalosis in ten, chronic allograft nephropathy in six, rejection in five and other causes in five. Delay in PH diagnosis until after transplant favored early graft loss (p = 0.07). K + L had better kidney graft outcomes than K with death-censored graft survival 95{\%} versus 56{\%} at 3 years (p = 0.011). Among 29 year 2000-09 first transplants (24 K + L), 84{\%} were functioning at 3 years compared to 55{\%} of earlier transplants (p = 0.05). At 6.8 years after transplantation, 46 of 58 patients are living (43 with functioning grafts). Outcomes of transplantation in PH have improved over time, with recent K + L transplantation highly successful. Recurrent oxalosis accounted for a minority of kidney graft losses.",
keywords = "Kidney transplantation, liver transplantation, oxalosis, primary hyperoxaluria",
author = "Bergstralh, {E. J.} and Monico, {C. G.} and Lieske, {John C} and Herges, {R. M.} and Langman, {C. B.} and B. Hoppe and Milliner, {D. S.}",
year = "2010",
month = "11",
doi = "10.1111/j.1600-6143.2010.03271.x",
language = "English (US)",
volume = "10",
pages = "2493--2501",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",
number = "11",

}

TY - JOUR

T1 - Transplantation outcomes in primary hyperoxaluria

AU - Bergstralh, E. J.

AU - Monico, C. G.

AU - Lieske, John C

AU - Herges, R. M.

AU - Langman, C. B.

AU - Hoppe, B.

AU - Milliner, D. S.

PY - 2010/11

Y1 - 2010/11

N2 - Optimal transplantation strategies are uncertain in primary hyperoxaluria (PH) due to potential for recurrent oxalosis. Outcomes of different transplantation approaches were compared using life-table methods to determine kidney graft survival among 203 patients in the International Primary Hyperoxaluria Registry. From 1976-2009, 84 kidney alone (K) and combined kidney and liver (K + L) transplants were performed in 58 patients. Among 58 first kidney transplants (32 K, 26 K + L), 1-, 3-and 5-year kidney graft survival was 82%, 68% and 49%. Renal graft loss occurred in 26 first transplants due to oxalosis in ten, chronic allograft nephropathy in six, rejection in five and other causes in five. Delay in PH diagnosis until after transplant favored early graft loss (p = 0.07). K + L had better kidney graft outcomes than K with death-censored graft survival 95% versus 56% at 3 years (p = 0.011). Among 29 year 2000-09 first transplants (24 K + L), 84% were functioning at 3 years compared to 55% of earlier transplants (p = 0.05). At 6.8 years after transplantation, 46 of 58 patients are living (43 with functioning grafts). Outcomes of transplantation in PH have improved over time, with recent K + L transplantation highly successful. Recurrent oxalosis accounted for a minority of kidney graft losses.

AB - Optimal transplantation strategies are uncertain in primary hyperoxaluria (PH) due to potential for recurrent oxalosis. Outcomes of different transplantation approaches were compared using life-table methods to determine kidney graft survival among 203 patients in the International Primary Hyperoxaluria Registry. From 1976-2009, 84 kidney alone (K) and combined kidney and liver (K + L) transplants were performed in 58 patients. Among 58 first kidney transplants (32 K, 26 K + L), 1-, 3-and 5-year kidney graft survival was 82%, 68% and 49%. Renal graft loss occurred in 26 first transplants due to oxalosis in ten, chronic allograft nephropathy in six, rejection in five and other causes in five. Delay in PH diagnosis until after transplant favored early graft loss (p = 0.07). K + L had better kidney graft outcomes than K with death-censored graft survival 95% versus 56% at 3 years (p = 0.011). Among 29 year 2000-09 first transplants (24 K + L), 84% were functioning at 3 years compared to 55% of earlier transplants (p = 0.05). At 6.8 years after transplantation, 46 of 58 patients are living (43 with functioning grafts). Outcomes of transplantation in PH have improved over time, with recent K + L transplantation highly successful. Recurrent oxalosis accounted for a minority of kidney graft losses.

KW - Kidney transplantation

KW - liver transplantation

KW - oxalosis

KW - primary hyperoxaluria

UR - http://www.scopus.com/inward/record.url?scp=78349247929&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78349247929&partnerID=8YFLogxK

U2 - 10.1111/j.1600-6143.2010.03271.x

DO - 10.1111/j.1600-6143.2010.03271.x

M3 - Article

VL - 10

SP - 2493

EP - 2501

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

IS - 11

ER -